Technology
Health
Biotechnology

InflaRx

1,009

$3.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.32%) As of 10:25 AM EDT today
-$0.01 (-0.32%) Today

Why Robinhood?

You can buy or sell InflaRx and other stocks, options, ETFs, and crypto commission-free!

About IFRX

InflaRx N.V. Common Stock, also called InflaRx, is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Read More Its products includes IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

CEO
Niels Christoph Riedemann
Employees
38,000
Headquarters
Jena, Thueringen
Founded
2007
Market Cap
89.02M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
737.72K
High Today
$3.65
Low Today
$3.57
Open Price
$3.65
Volume
24.64K
52 Week High
$53.10
52 Week Low
$2.17

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
2017 IPO
Europe (Non-UK)

IFRX Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Apr 13, Pre-Market

People Also Bought

Inpixon

28,815

$1.28

+7.56%

Inpixon

28,815

$1.28

+7.56%

Biocept

35,192

$0.2748

-2.52%

Aurora Cannabis

845,590

$0.9393

-8.81%

Ocugen, Inc

14,922

$0.2834

-5.50%

You May Also Like

CHNGU
IP
MFL
FNGS
PPDM
DK
HTY
HCI
MHO
LOMA
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy IFRX

Market Price$3.59
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell InflaRx stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up